National Bank of Canada’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$135K Hold
2,505
﹤0.01% 1728
2025
Q4
$140K Buy
2,505
+50
+2% +$2.59K ﹤0.01% 1681
2025
Q3
$118K Buy
2,455
+50
+2% +$2.24K ﹤0.01% 1710
2025
Q2
$97.4K Sell
2,405
-270
-10% -$10.9K ﹤0.01% 1791
2025
Q1
$117K Sell
2,675
-75
-3% -$3.31K ﹤0.01% 1658
2024
Q4
$118K Hold
2,750
﹤0.01% 1725
2024
Q3
$122K Buy
2,750
+150
+6% +$6.42K ﹤0.01% 1494
2024
Q2
$103K Hold
2,600
﹤0.01% 1471
2024
Q1
$105K Sell
2,600
-200
-7% -$8.62K ﹤0.01% 1541
2023
Q4
$117K Sell
2,800
-500
-15% -$18.9K ﹤0.01% 1541
2023
Q3
$128K Sell
3,300
-150
-4% -$6.35K ﹤0.01% 1580
2023
Q2
$141K Sell
3,450
-70
-2% -$2.89K ﹤0.01% 1534
2023
Q1
$144K Sell
3,520
-530
-13% -$22.3K ﹤0.01% 1468
2022
Q4
$166K Sell
4,050
-50
-1% -$2.08K ﹤0.01% 1499
2022
Q3
$163K Sell
4,100
-750
-15% -$32.1K ﹤0.01% 1415
2022
Q2
$204K Sell
4,850
-550
-10% -$23.1K ﹤0.01% 1420
2022
Q1
$244K Sell
5,400
-2,385
-31% -$105K ﹤0.01% 1459
2021
Q4
$359K Buy
+7,785
New +$369K ﹤0.01% 1333

Other funds holding XPH